Home > Healthcare > Medical Devices > Therapeutic Devices > Bone Graft Substitutes Market

Bone Graft Substitutes Market Share

Report ID: GMI7993
Published Date: Jan 2024
Report Format: PDF

Download Free Sample

Bone Graft Substitutes Market Share

Key market players are focusing on innovating and improving bone graft substitutes to enhance effectiveness and safety while gaining competitive edges. They are investing in research to develop advanced materials and techniques. These companies are also introducing more sophisticated and cost-effective products as well as leveraging technological advancements to meet the growing demand for bone repair solutions.

Bone Graft Substitutes Market Companies

AlloSource
Baxter International Inc.
DePuy Synthes (Johnson & Johnson Inc.)
Geistlich Pharma AG
Medtronic plc
NuVasive, Inc.
Orthofix US LLC.
OST Laboratories
Smith + Nephew
Stryker Corporation
Zimmer Biomet Holdings, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global bone graft substitutes market was valued at over USD 3 billion in 2023 and is estimated to expand at 6.6% CAGR from 2024 to 2032 due to the rising incidence of orthopedic conditions worldwide.

The allograft segment in the bone graft substitutes market is poised to expand at 6.4% CAGR from 2024 to 2032, fueled by wide utilization in orthopedic procedures particularly for their compatibility and effectiveness in promoting bone regeneration.

North America Bone Graft Substituents Market is expected to record 6.1% CAGR through 2032 due to the increasing preference for minimally invasive surgeries and rapid advancements in medical technology.

AlloSource, Baxter International Inc., DePuy Synthes (Johnson & Johnson Inc.), Geistlich Pharma AG, Medtronic plc, NuVasive, Inc., Orthofix US LLC., OST Laboratories, Smith + Nephew, Stryker Corporation and Zimmer Biomet Holdings, Inc.